Author pages are created from data sourced from our academic publisher partnerships and public sources.
A novel and well tolerated mite allergoid subcutaneous immunotherapy: evidence of clinical and immunologic efficacy
- A. Roger, N. Depreux, Yani Jurgens, M. Heath, G. García, M. Skinner
- Immunity, inflammation and disease
- 29 May 2014
Allergy to house dust mite is one of the most common causes of allergic rhinitis. A novel tyrosine‐adsorbed, modified allergen product, Acarovac Plus, developed for the treatment of perennial mite… Expand
A novel microcrystalline tyrosine-adsorbed, mite-allergoid subcutaneous immunotherapy: 1-year follow-up report.
AIM A 1-year follow-up study comparing the safety and tolerability of the dosing schedules, satisfaction and effectiveness of a novel microcrystalline tyrosine-adsorbed mite (Dermatophagoides… Expand
DIRAE study: seasonal allergic rhinitis distribution in Spain.
BACKGROUND National epidemiological study to observe if among patients with pollinic seasonal allergic rhinitis (SAR), there are differences between those visited by primary care physicians (GPs) or… Expand
Food allergy in Catalonia: Clinical manifestations and its association with airborne allergens.
BACKGROUND Food allergy affects around 6% of the European population and its prevalence worldwide has been increasing in the last decades, but studies focused on investigating food allergy… Expand
Negative allergy study in a case of postorgasmic illness syndrome (POIS).
Postorgasmic illness syndrome (POIS) is a rarely described syndrome characterized by transient flu-like symptoms and cognition disorders. Recent studies suggest that immunogenic reactivity to… Expand
Component-Resolved Diagnosis: Impact on Indications for Therapy in Patients With Respiratory Allergy and Sensitization to Multiple Pollens in Catalonia, Spain.
[Lymphocytopenia following radiation therapy: probably common but unknown].
Linfocitopenia tras radioterapia: probablemente frecuente, pero desconocida
Falsa hipersensibilidad a mesalazina como causa de escalamiento terapéutico
Resumen La mesalazina es el farmaco de eleccion en pacientes con formas leves-moderadas de colitis ulcerosa, tanto para inducir la remision clinica como para su mantenimiento. De hecho, la mitad de… Expand
Immunotheraphy in Allergic Diseases.
- A. Roger, M. Basagaña, +6 authors E. Martínez-Cáceres
- Current pharmaceutical design
- 28 February 2018
The prevalence of allergic diseases is increasing worldwide. It is estimated that more than 30% of the world population is now affected by one or more allergic conditions and a high proportion of… Expand